Frontline Aspacytarabine with Venetoclax for Older/Unfit Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase 1 Study

被引：0

作者：

Altman, Jessica K. ^{[1
]}

Abaza, Yasmin ^{[2
]}

Keng, Michael ^{[3
]}

Maiti, Abhishek ^{[4
]}

Koprivnikar, Jamie ^{[5
]}

Tessler, Shoshi ^{[6
]}

Blumberg, Chen ^{[6
]}

Flaishon, Liat ^{[6
]}

Ben Yakar, Ruth ^{[6
]}

机构：

[1] Northwestern Univ, Chicago, IL 60611 USA

[2] Northwestern Med, Chicago, IL USA

[3] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[6] BioSight Ltd, Tel Aviv, Israel

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-185694

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Azacitidine, Venetoclax and Pevonedistat As Frontline Therapy for Patients with Secondary Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy: Results from a Phase I/II Study
Short, Nicholas J.
Montalban-Bravo, Guillermo
Alvarado, Yesid
Konopleva, Marina
Jabbour, Elias J.
Garcia-Manero, Guillermo
Yilmaz, Musa
Jain, Nitin
Borthakur, Gautam
DiNardo, Courtney D.
Daver, Naval
Issa, Ghayas C.
Ohanian, Maro
Pemmaraju, Naveen
Sasaki, Koji
Maiti, Abhishek
Chien, Kelly S.
Ravandi, Farhad
Kadia, Tapan M.
Andreeff, Michael
Muftuoglu, Muharrem
Delumpa, Ricardo
Bose, Prithviraj
Pierce, Sherry A.
Waller, Lourdes
Banks, Glenda
Kantarjian, Hagop
Cortes, Jorge E.
BLOOD, 2021, 138
[2] A Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naive Acute Myeloid Leukemia
Jonas, Brian A.
Welborn, Jeanna L.
Esteghamat, Naseem S.
Hoeg, Rasmus T.
Rosenberg, Aaron S.
Molnar, Laura
Dang-Chu, Ashley Linh
Stewart, Susan L.
Tuscano, Joseph M.
BLOOD, 2022, 140 : 6213 - 6214
[3] Efficacy of hypomethylating agents and Venetoclax in unfit patients with acute myeloid leukemia
Rieger, M.
Manz, M. G.
Muller, R.
Theocharides, A. P. A.
Schwotzer, R.
SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
[4] Management of older or unfit patients with acute myeloid leukemia
R B Walter
E H Estey
Leukemia, 2015, 29 : 770 - 775
[5] Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study
Bazinet, Alexandre
Garcia-Manero, Guillermo
Short, Nicholas
Alvarado, Yesid
Bataller, Alex
Abuasab, Tareq
Islam, Rabiul
Montalbano, Kathryn
Issa, Ghayas
Maiti, Abhishek
Yilmaz, Musa
Jain, Nitin
Masarova, Lucia
Kornblau, Steven
Jabbour, Elias
Montalban-Bravo, Guillermo
Rausch, Caitlin R.
Pierce, Sherry
Dinardo, Courtney
Kadia, Tapan
Daver, Naval
Konopleva, Marina
Huang, Xuelin
Kantarjian, Hagop
Ravandi, Farhad
LANCET HAEMATOLOGY, 2024, 11 (04): : e276 - e286
[6] Management of older or unfit patients with acute myeloid leukemia
Walter, R. B.
Estey, E. H.
LEUKEMIA, 2015, 29 (04) : 770 - 775
[7] A Phase 2 Study of the Fully Oral Combination of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax for Older and/or Unfit Patients with Acute Myeloid Leukemia
Bazinet, Alexandre
Garcia-Manero, Guillermo
Short, Nicholas J.
Valero, Yesid Alvarado
Abuasab, Tareq
Islam, Md Rabiul
Montalbano, Kathryn
Issa, Ghayas C.
Maiti, Abhishek
Yilmaz, Musa
Jain, Nitin
Masarova, Lucia
Kornblau, Steven M.
Jabbour, Elias
Montalban-Bravo, Guillermo
Pierce, Sherry
DiNardo, Courtney D.
Kadia, Tapan M.
Daver, Naval
Konopleva, Marina Y.
Kantarjian, Hagop M.
Ravandi, Farhad
BLOOD, 2023, 142
[8] Treatment options for older unfit patients with acute myeloid leukemia
Tang, Hailong
Jia, Shuangshuang
Bi, Lei
Jia, Weijing
Gao, Guangxun
FUTURE ONCOLOGY, 2021, 17 (07) : 837 - 851
[9] Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Keith W. Pratz
Panayiotis Panayiotidis
Christian Recher
Xudong Wei
Brian A. Jonas
Pau Montesinos
Vladimir Ivanov
Andre C. Schuh
Courtney D. DiNardo
Jan Novak
Vlatko Pejsa
Don Stevens
Su-Peng Yeh
Inho Kim
Mehmet Turgut
Nicola Fracchiolla
Kazuhito Yamamoto
Yishai Ofran
Andrew H. Wei
Cat N. Bui
Katy Benjamin
Rajesh Kamalakar
Jalaja Potluri
Wellington Mendes
Jacob Devine
Walter Fiedler
Blood Cancer Journal, 12
[10] Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Pratz, Keith W.
Panayiotidis, Panayiotis
Recher, Christian
Wei, Xudong
Jonas, Brian A.
Montesinos, Pau
Ivanov, Vladimir
Schuh, Andre C.
DiNardo, Courtney D.
Novak, Jan
Pejsa, Vlatko
Stevens, Don
Yeh, Su-Peng
Kim, Inho
Turgut, Mehmet
Fracchiolla, Nicola
Yamamoto, Kazuhito
Ofran, Yishai
Wei, Andrew H.
Bui, Cat N.
Benjamin, Katy
Kamalakar, Rajesh
Potluri, Jalaja
Mendes, Wellington
Devine, Jacob
Fiedler, Walter
BLOOD CANCER JOURNAL, 2022, 12 (04)

← 1 2 3 4 5 →